<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04581421</url>
  </required_header>
  <id_info>
    <org_study_id>LICARB ID PhD010-19.</org_study_id>
    <nct_id>NCT04581421</nct_id>
  </id_info>
  <brief_title>The Role of Dietary Carbohydrate and Fat Availability in the Regulation of Hepatic Lipid Content</brief_title>
  <acronym>LICARB</acronym>
  <official_title>The Role of Dietary Carbohydrate and Fat Availability in the Regulation of Hepatic Lipid Content</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hvidovre University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Danish Research Centre for Magnetic Resonance</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hvidovre University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate dietary compositions effect on liverfat measured&#xD;
      by magnetic resonance imaging.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Overweight but otherwise healthy men will be included in the study which is a randomized diet&#xD;
      intervention study in a cross over design.&#xD;
&#xD;
      The study involves 2 intervention periods of 5 days each, during which the participant&#xD;
      ingests two different types of experimental diet. Participants will in randomized order&#xD;
      (determined by block randomization) ingest a diet with low carbohydrate and high fat content,&#xD;
      and a diet with high carbohydrate and low fat content.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 21, 2020</start_date>
  <completion_date type="Anticipated">August 2023</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Randomized diet intervention study in a cross over design</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Liverfat</measure>
    <time_frame>(MRS Day -1 (before intervention starts), Day 5 (after diet intervention is completed)</time_frame>
    <description>The effect of high-carbohydrate/low-fat vs low-carbohydrate/high-fat diet on change in MRS determined liver fat.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Glycogen</measure>
    <time_frame>(MRS Day -1 (before intervention starts), Day 5 (after diet intervention is completed)</time_frame>
    <description>effect of the low-carbohydrate/high-fat intake and high-carbohydrate/low-fat intake on hepatic glycogen content measured by 7T 13C-MRS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fasting hepatic glucose output</measure>
    <time_frame>(Day 0 and Day 6 of the diet intervention)</time_frame>
    <description>measured by Ra of glucose= (infusion rate of 6,6 2H2-glucose)/TTR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fasting blood triacylglycerol concentration</measure>
    <time_frame>(Day 0 and Day 6 of the diet intervention)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin clearance determined during steady state insulin infusion</measure>
    <time_frame>(Day 0 and Day 6 of the diet intervention)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">14</enrollment>
  <condition>NAFLD</condition>
  <condition>Overweight and Obesity</condition>
  <condition>Metabolic Syndrome</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>High Carb first</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Low Carb first</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>High Carb Low Fat Diet</intervention_name>
    <description>The participants will be randomized to a diet of low carb/ high fat og high carb/low fat</description>
    <arm_group_label>High Carb first</arm_group_label>
    <arm_group_label>Low Carb first</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Low Carb High Fat Diet</intervention_name>
    <description>The participants will be randomized to a diet of low carb/ high fat og high carb/low fat</description>
    <arm_group_label>High Carb first</arm_group_label>
    <arm_group_label>Low Carb first</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy men being 18-50 years old.&#xD;
&#xD;
          -  Overweight (BMI 25-35)&#xD;
&#xD;
          -  Low to moderate physical activity level, defined as ≤ 1 weekly session of aerobic&#xD;
             exercise.&#xD;
&#xD;
          -  Non-smokers&#xD;
&#xD;
          -  No use of medicine&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Fasting blood glucose indicating overt diabetes (≥7 mmol/l)&#xD;
&#xD;
          -  HbA1C &gt;48 mmol/mol&#xD;
&#xD;
          -  Fasting plasma triacylglycerol indicating dyslipidemia (≥2.2 mmol/l)&#xD;
&#xD;
          -  FIB-4 score &gt;1.45&#xD;
&#xD;
          -  Contraindications for MR-scan: abdominal height exceed limitations of the MR-scanner,&#xD;
             pacemaker or other electronic device implanted, implanted metal devices, severe&#xD;
             claustrophobia.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 25, 2020</study_first_submitted>
  <study_first_submitted_qc>October 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2020</study_first_posted>
  <last_update_submitted>October 5, 2020</last_update_submitted>
  <last_update_submitted_qc>October 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hvidovre University Hospital</investigator_affiliation>
    <investigator_full_name>Kirstine Nyvold Bojsen-Moeller</investigator_full_name>
    <investigator_title>Principal investigator, MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

